Evidence map›Paper›PMID 35889168›Full record

ArticleMicroorganisms2022

Burcu Isler, David L Paterson, Patrick N A Harris, Weiping Ling, Felicity Edwards, Claire M Rickard, Timothy J Kidd, Ian Gassiep, Kevin B Laupland

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Biomedical reports · 2026
    Review
  2. Epidemiology ofNew microbes and new infections · 2026
    Article
  3. Establishment ofFrontiers in microbiology · 2026
    Article
  4. Article
  5. Observational
  6. Antimicrobial agents and chemotherapy · 2023
    Article
  7. Therapeutic advances in respiratory disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Burcu IslerUQ Centre for Clinical Research, Faculty of Medicine, University of Queensland, RBWH Campus, Brisbane 4029, Australia.
David L PatersonUQ Centre for Clinical Research, Faculty of Medicine, University of Queensland, RBWH Campus, Brisbane 4029, Australia.
Patrick N A HarrisUQ Centre for Clinical Research, Faculty of Medicine, University of Queensland, RBWH Campus, Brisbane 4029, Australia.ORCID 0000-0002-2895-0345
Weiping LingUQ Centre for Clinical Research, Faculty of Medicine, University of Queensland, RBWH Campus, Brisbane 4029, Australia.ORCID 0000-0001-5803-3831
Felicity EdwardsFaculty of Health, School of Clinical Sciences, Queensland University of Technology, Brisbane 4072, Australia.
Claire M RickardUQ Centre for Clinical Research, Faculty of Medicine, University of Queensland, RBWH Campus, Brisbane 4029, Australia.ORCID 0000-0002-6341-7415
Timothy J KiddCentral Microbiology Laboratory, Pathology Queensland, Brisbane 4006, Australia.ORCID 0000-0002-6135-6364
Ian GassiepUQ Centre for Clinical Research, Faculty of Medicine, University of Queensland, RBWH Campus, Brisbane 4029, Australia.ORCID 0000-0003-3548-6963
Kevin B LauplandRoyal Brisbane and Women's Hospital, Brisbane 4029, Australia.
The University of Queensland · AUQueensland University of Technology · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCase reports and small series indicate that

methodsRetrospective, laboratory-based surveillance was conducted in Queensland, Australia (population ≈ 5 million) during 2000-2019. Clinical and outcome data were obtained by linkage to state hospital admissions and vital statistics databases. BSI diagnosed within the community or within the first two calendar days of stay in hospital were classified as community-onset. Community-onset BSIs were grouped into community-associated and healthcare-associated.

resultsDuring more than 86 million person-years of surveillance, 210 incidents of

conclusionsAlthough comorbidity is an important determinant of risk, most

Indexed as

Achromobacterbloodstream infectionincidence

Identifiers

PMID35889168
PMCPMC9323057
OpenAlexW4285729534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.